Also new this year, a series of talks will illustrate How to Apply the New ACR Guidelines, with a variety of case-based examples of how to implement new clinical recommendations for gout, giant cell arteritis, Takayasu’s arteritis and polyarteritis nodosa.
Rheumatology knowledge is fueled by open discussion that welcomes conflicting opinions. The 2019 Great Debate will tackle both sides of this clinical conundrum. Anabolic Agents Are/Are Not Appropriate First-Line Therapy for Glucocorticoid-Induced Osteoporosis will be a timely question in the wake of the 2017 ACR Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Dive into the discussion, and vote for the debate’s winner with a real-time response tool.
Eager to discuss cutting-edge, even controversial topics? Sessions at the 2019 Annual Meeting will delve into the mechanisms of cannabinoids for rheumatology pain management, the latest data on vaccines and opportunistic infection risk, neurologic manifestations of gout, and innovative, non-drug interventions to treat pain in hip, knee or hand osteoarthritis.
“There’s a culture of excellence at the ACR,” says Dr. Marchetta. “There is also a culture of flexibility. We have this great opportunity to try some new approaches to education. Everyone is really excited about the possibilities!”
Visit the 2019 ACR/ARP Annual Meeting Online Program to learn more about this year’s sessions.
Join Us at the Annual Meeting
The 2019 ACR/ARP Annual Meeting, Nov. 8–13, in Atlanta is your gateway to global rheumatology education. View the Online Program to find out more about the opportunities for professional development and networking, and obtain firsthand access to the latest rheumatology research and clinical applications. Register now, and don’t miss out.
